Mark Kroese
Overview
Explore the profile of Mark Kroese including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
282
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pezzullo A, Gris A, Scarsi N, Tona D, Porcelli M, Di Pumpo M, et al.
J Clin Epidemiol
. 2025 Feb;
:111729.
PMID: 39986491
Objective: Genetic and genomic tests are the cornerstone of personalized preventive approaches. Inconsistency in evaluating their clinical utility is often cited as a reason for their limited implementation in clinical...
2.
Pastorino R, Pezzullo A, Osti T, Adany R, Borry P, Barnhoorn F, et al.
Eur J Cancer Prev
. 2024 Apr;
33(5):387-389.
PMID: 38598497
No abstract available.
3.
Hill M, Ellard S, Fisher J, Fulop N, Knight M, Kroese M, et al.
NIHR Open Res
. 2023 Oct;
2:10.
PMID: 35935673
Background: Prenatal exome sequencing (ES) for the diagnosis of fetal anomalies was implemented nationally in England in October 2020 by the NHS Genomic Medicine Service (GMS). is the GMS is...
4.
Moorthie S, de Villiers C, Burton H, Kroese M, Antoniou A, Bhattacharjee P, et al.
Prev Med
. 2022 May;
159:107075.
PMID: 35526672
Advances in knowledge about breast cancer risk factors have led to the development of more comprehensive risk models. These integrate information on a variety of risk factors such as lifestyle,...
5.
Moorthie S, Hall A, de Villiers C, Janus J, Brigden T, Blackburn L, et al.
Per Med
. 2022 Mar;
19(3):263-270.
PMID: 35289204
As common low penetrance variants associated with diseases are uncovered, attempts continue to be made to harness this knowledge for improving healthcare. Polygenic scores have been developed as the mechanism...
6.
de Villiers C, Kroese M, Moorthie S
J Med Genet
. 2020 May;
57(11):725-732.
PMID: 32376789
The use of genomic information to better understand and prevent common complex diseases has been an ongoing goal of genetic research. Over the past few years, research in this area...
7.
Pokorska-Bocci A, Stewart A, Sagoo G, Hall A, Kroese M, Burton H
Per Med
. 2018 May;
11(2):197-210.
PMID: 29751382
Over the last decade genomics and other molecular biosciences have enabled new capabilities that, according to many, have the potential to revolutionize medicine and healthcare. These developments have been associated...
8.
Hall A, Finnegan T, Chowdhury S, Dent T, Kroese M, Burton H
J Community Genet
. 2018 Feb;
9(3):195-199.
PMID: 29470710
Risk prediction models have a key role in stratified disease prevention, and the incorporation of genomic data into these models promises more effective personalisation. Although the clinical utility of incorporating...
9.
Chitty L, Wright D, Hill M, Verhoef T, Daley R, Lewis C, et al.
BMJ
. 2016 Jul;
354:i3426.
PMID: 27378786
Objective: To investigate the benefits and costs of implementing non-invasive prenatal testing (NIPT) for Down's syndrome into the NHS maternity care pathway. Design: Prospective cohort study. Setting: Eight maternity units...
10.
Warren-Gash C, Kroese M, Burton H, Pharoah P
Hered Cancer Clin Pract
. 2016 Jun;
14:12.
PMID: 27252788
Background: The decision to test for high risk breast cancer gene mutations is traditionally based on risk scores derived from age, family and personal cancer history. Next generation sequencing technologies...